Eam Global Investors LLC Cyma Bay Therapeutics, Inc. Transaction History

Eam Global Investors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.22 - $6.27 $1 Million - $1.96 Million	311,808 New	311,808 $1.96 Million
Q4 2020 Feb 11, 2021	SELL	$5.73 - $9.03 $1.63 Million - $2.57 Million	-284,534 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.32 - $7.24 $944,652 - $2.06 Million	284,534 New	284,534 $2.06 Million
Q3 2018 Nov 08, 2018	SELL	$10.88 - $14.52 $727,676 - $971,126	-66,882 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$10.66 - $14.38 $260,551 - $351,475	-24,442 Reduced 26.76%	66,882 $898,000
Q1 2018 Jun 04, 2018	SELL	$9.0 - $15.16 $168,102 - $283,158	-18,678 Reduced 16.98%	91,324 $1.19 Million
Q4 2017 Jun 04, 2018	BUY	$7.67 - $9.31 $843,715 - $1.02 Million	110,002	110,002 $1.01 Million

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.